Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors
Phase 1
Completed
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- Interventions
- First Posted Date
- 2012-10-25
- Last Posted Date
- 2019-03-01
- Lead Sponsor
- Manisha Shah
- Target Recruit Count
- 23
- Registration Number
- NCT01713972
- Locations
- 🇺🇸
Ohio State University Medical Center, Columbus, Ohio, United States
🇺🇸University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States
News
No news found